- Asbestos Exposure
- Consumer Fraud
- Human Rights
- Medical Devices
- Medical Drugs
- Nursing Home Abuse & Neglect
- Personal Injury & Wrongful Death
- Securities Class Actions
- Toxic Exposure
July 6, 2016
Metal-on-metal hip devices were originally thought to be a more durable alternative to ceramic or plastic models, but some studies have shown that they may deteriorate faster, expose patients to high levels of metals such as cobalt and chromium, and fail at a higher rate than older implants.
In fact, approximately one in 12 recipients of metal-on-metal devices may require corrective surgery within five years of implantation.
Side effects may include:
Any of the above symptoms or related conditions that result in revision surgery to remove a hip device.
If you received a metal hip implant and have experienced any of the symptoms listed above, contact your physician immediately. Also, do not release any medical information to the hip replacement manufacturer representatives or sign a release before speaking to a lawyer. If you are told that you need hip revision surgery, make sure that the removed component parts are preserved and consult your counsel to ensure they are saved correctly.
Our lawyers represent patients and are reviewing new claims in metal-on-metal hip replacement cases, including those involving:
If you or someone you love is experiencing one or more of the side effects listed above or are suffering following metal hip replacement surgery, contact medical attorneys John Duane or Don Migliori by email or call 1.800.768.4026 for a free initial consultation and to discuss if you may have a case.
Biomet M2a-Magnum™ Metal-on-Metal Hip Device
We are longer accepting Biomet M2a-Magnum metal-on-metal hip replacement cases, but if you have questions about these cases, please contact medical attorney John Duane by email or call 1.800.768.4026.
Medical attorney Don Migliori currently serves on the Plaintiffs’ Steering Committee for both the DePuy ASR XL multidistrict litigation (In re DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation) and the DePuy Pinnacle multidistrict litigation (In re DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation).
There has been controversy surrounding whether the benefit of metal hip implants outweighs the potential risks. In June 2012, the FDA held a two-day advisory panel meeting to discuss the thousands of adverse event reports received by the agency regarding metal-on-metal devices, results from medical studies and how to monitor the more than half million U.S. patients with metal hip replacements. As part of its investigation, the FDA “has asked manufacturers like Johnson & Johnson, Zimmer Holdings Inc. and Biomet Inc. to conduct long-term, follow-up studies of more than 100 metal-on-metal hips on the U.S. market.”
In January 2013, The New York Times reported that a 2011 internal study conducted by Johnson & Johnson found that the ASR metal-on-metal device could potentially fail in nearly 40 percent of implanted patients.
The Journal of Bone & Joint Surgery states that the revision rate for the Stryker ABG II device is much higher than expected, requiring some patients to have the device surgically removed relatively soon after implantation.
Following complaints of agonizing pain in a number of his patients who received Zimmer Durom cup hip replacements, The New York Times reports that veteran orthopedic surgeon Dr. Lawrence Dorr contacted Zimmer about his concerns but heard nothing back. It wasn’t until Dr. Dorr raised his concerns with the American Association of Hip and Knee Surgeons that Zimmer began to investigate the issue.